|
|
|
| Analysis effect of aerosol inhalation of Budesonide and Ipratropium bromide in the treatment of senile chronic obstructive pulmonary disease |
| SONG Lin-yuan |
| Department of Anesthesiology,Tian Jiabing Hospital of Traditional Chinese Medicine Hospital of Meizhou City,Guangdong Province,Meizhou 514000,China |
|
|
|
|
Abstract ObjectiveTo explore the clinical therapeutic effect of aerosol inhalation of Budesonide and Ipratropium bromide in the treatment of senile chronic obstructive pulmonary disease.MethodsFrom January 2015 to June 2016,60 patients with moderate to severe chronic obstructive pulmonary disease were selected as research object.They were randomly divided into study group and control group by random number table,30 cases in each group.The study group were given inhaled Budesonide and Ipratropium bromide treatment,the control group were given inhaled with stioke physiscogical saline solation.Peak airway pressure of 10 min before and after treatment with 5 min,SpO2,arterial blood gas pH value,partial pressure of oxygen,partial pressure of carbon dioxide of before anesthesia without oxygen state and after anesthesia recovery without oxygen inhalation after 10 min were observed and compared between the two groups.ResultsBefore the treatment of 5 min two groups of patients with peak pressure,the difference had no statistical significance(P＞0.05),after the treatment of airway 10 min study group of patients with peak pressure was significantly lower than the control group.The SpO2,PaO2of the study group of patients were significantly higher than the control group,the partial pressure of carbon dioxide was significantly lower than the control group;the success rate of postoperative 1 h in the study group was 90.00%,which was significantly higher than that of the control group of 56.67%;the differences were statistically significant(P＜0.05).ConclusionThe clinical treatment effect of the inhalation of Budesonide and Ipratropium bromide in the treatment of senile chronic obstructive pulmonary disease is remarkable.It is an ideal choice for clinical practice.
|
|
|
|
|
|
| [1] |
白丽华，胡晓慧，张萍.国产噻托溴铵雾化吸入治疗慢性阻塞性肺病的应用价值分析[J].中国医刊，2015，11（9）：71－73.
|
| [2] |
张朝阳，钟祥柱，罗润嫦，等.普米克令舒雾化吸入治疗慢性阻塞性肺病急性加重期并Ⅱ型呼吸衰竭临床分析[J].河北医药，2015，37（11）：1709－1710.
|
| [3] |
杨华，孙强.渐进式雾化吸入治疗慢性阻塞性肺病患者的效果观察[J].国际护理学杂志，2015，11（5）：707－708.
|
| [4] |
陈祥.布地奈德混悬液联合硫酸特布他林雾化吸入治疗慢性阻塞性肺病急性加重期的效果[J].实用临床医药杂志， 2016，20（11）：154－155.
|
| [5] |
杜璐玲.头孢哌酮舒巴坦钠静滴加雾化治疗老年性慢性阻塞性肺病合并感染的疗效观察[J].北方药学，2014，11（7）：22－23.
|
| [6] |
魏岳斌，吴坤显，潘林平，等.防己泻肺汤联合中药雾化吸入治疗慢性阻塞性肺病急性加重期的临床研究[J].中西医结合研究，2015，11（4）：169－172.
|
| [7] |
陈宁，徐燕，张永红，等.慢性阻塞性肺病大鼠外周血中Foxp3+调节性 T 细胞及 IL－17、IL－6 水平的变化[J].中国现代医学杂志，2014，24（27）：24－28.
|
| [8] |
霍伟君.呋塞米混合地塞米松雾化对支气管哮喘及慢性阻塞性肺病急性期的治疗效果[J].岭南急诊医学杂志，2016，21（5）：512－514.
|
| [9] |
王桂丽，秦展.布地奈德联合特布他林、异丙托溴胺雾化吸入治疗慢性阻塞性肺病急性加重期的效果评价[J].中西医结合心血管病电子杂志，2014，11（3）：62－63.
|
| [10] |
李现东，韩纪昌，李磊，等.肿瘤坏死因子－α和可溶性肿瘤坏死因子受体在慢性阻塞性肺病患者肺功能变化中的表达及意义[J].中国老年学杂志，2014，34（2）：57－58.
|
| [11] |
袁光雄，付林，孙卫平，等.小剂量糖皮质激素对皮质醇不足的慢性阻塞性肺病急性加重期患者的影响[J].中华急诊医学杂志，2014，23（5）：543－548.
|
| [12] |
陈晔锋，沈巨信，余月芳，等.慢性阻塞性肺病患者肺功能与心腔大小及心功能不全的相关性[J].中国老年学杂志，2016，36（22）：5657－5659.
|
| [13] |
吴翠仪，齐亚飞，郑晓茹.慢性阻塞性肺病稳定期患者生活质量与下呼吸道细菌定植及炎症反应的相关性[J].中国老年学杂志，2016，36（21）：5375－5377.
|
| [14] |
郝习君，王静，陈长香.综合干预提高老年慢性阻塞性肺病患者记忆功能的疗效[J].中国老年学杂志，2016，36（20）：5172－5173.
|
| [15] |
黄榜江，肖政，汪成琼，等.我国慢性阻塞性肺病院内真菌感染特征及高危药物因素的Meta分析[J].实用医学杂志， 2015，31（1）：110－115.
|
| [16] |
李四维，张玲，李春雷，等.熏香烟加气管注入脂多糖和结合臭氧暴露法建立大鼠慢性阻塞性肺病模型[J].北京中医药大学学报，2014，37（5）：321－324.
|
|
|
|
